Summary & Overview
CPT 01930: Anesthesia for Peripheral Venous and Lymphatic Interventions
CPT 01930 captures anesthesia services for therapeutic interventional radiology procedures that target the peripheral venous and lymphatic systems. Nationally, this code is important for documenting anesthesia work associated with minimally invasive vascular therapies performed in outpatient hospital settings. Accurate use affects billing, clinical documentation, and payer adjudication across major commercial payers.
Key payers addressed in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. Readers will find a concise overview of the code’s clinical scope, common sites of service, and how it fits within interventional radiology anesthesia practice. The content outlines coding relationships to related interventional radiology anesthesia services and highlights common clinical diagnoses that may accompany the procedure.
This report provides practical benchmarks and policy context to inform billing and administrative teams, including typical site-of-care expectations and common procedural indications. It also identifies areas where billing clarity is commonly required and notes where input data was not provided. The summary is intended for a national audience of anesthesia providers, coding specialists, and revenue cycle professionals seeking clear guidance on the clinical and billing dimensions of CPT 01930.
CPT Code Overview
CPT 01930 describes anesthesia for therapeutic interventional radiological procedures involving the venous/lymphatic system (not to include access to the central circulation); not otherwise specified. This code applies to anesthesia services provided in the context of interventional radiology procedures where the primary therapeutic target is the peripheral venous or lymphatic system. The service type is Anesthesia – Interventional Radiology and the typical site of service is Outpatient Hospital (POS 22).
Clinical & Coding Specifications
Clinical Context
A patient with chronic sinonasal symptoms (nasal obstruction, congestion, recurrent sinus infections) presents for an interventional radiology–guided therapeutic procedure targeting the venous/lymphatic structures of the nasal/craniofacial region. The patient is evaluated pre-procedure by the anesthesiology team, cleared as an American Society of Anesthesiologists physical status P1 if otherwise healthy, and scheduled for outpatient hospital-based anesthesia. Monitored anesthesia care (QS) is commonly provided for comfort and procedural sedation while the interventional radiologist performs targeted venous/lymphatic interventions (for example, embolization or sclerotherapy of abnormal venous channels related to sinonasal pathology). The clinical workflow includes pre-anesthesia assessment, intra-procedural monitoring and sedation/anesthesia management by the anesthesiology service, post-anesthesia recovery in the ambulatory PACU, and discharge with routine post-procedure instructions.
Coding Specifications
-
Modifier
QS: Monitored anesthesia care service. Use when the anesthesia service provided is monitored anesthesia care rather than general anesthesia or regional block. -
Modifier
P1: A normal healthy patient. Use to indicate the ASA physical status of a patient who is healthy with no systemic disease. -
Associated provider taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207L00000X | Anesthesiology |
207LA0401X | Pain Medicine (Anesthesiology) |
207LC0200X | Critical Care Medicine (Anesthesiology) |
Related Diagnoses
-
J34.2— Deviated nasal septumClinical relevance: Deviated nasal septum can contribute to nasal obstruction and may be a comorbid anatomic factor in patients undergoing sinonasal or adjacent venous/lymphatic interventions.
-
J32.9— Chronic sinusitis, unspecifiedClinical relevance: Chronic sinusitis is associated with persistent sinonasal inflammation and may be part of the clinical picture when interventional radiology addresses venous or lymphatic contributors to chronic sinonasal disease.
-
J33.0— Polyp of nasal cavityClinical relevance: Nasal polyps can cause obstruction and recurrent sinus disease; they may coexist with vascular or lymphatic abnormalities addressed during therapeutic interventional procedures.
-
J34.89— Other specified disorders of nose and nasal sinusesClinical relevance: This code captures specified sinonasal disorders that may be relevant as indications or comorbidities in patients undergoing venous/lymphatic interventional procedures.
-
J34.3— Hypertrophy of nasal turbinatesClinical relevance: Turbinate hypertrophy contributes to nasal obstruction and may be noted in the pre-procedural assessment of patients having interventional radiology procedures in the sinonasal region.
Related CPT Codes
| CPT Code | Description |
|---|---|
01916 | Anesthesia for diagnostic arteriography/venography (bundled and not to be reported in conjunction) |
01916 is a related code representing anesthesia for diagnostic arteriography/venography. It is listed as bundled and should not be reported in conjunction with 01930. In clinical workflow, 01916 would apply when the procedure is diagnostic arteriography/venography rather than a therapeutic interventional radiological procedure involving the venous/lymphatic system; 01930 applies to anesthesia for therapeutic venous/lymphatic interventional radiology procedures (not including access to the central circulation).
National Reimbursement Benchmarks
National commercial mean rates exceed Medicare by a wide margin when comparing the average commercial benchmark (BUCA) to Medicare. The BUCA mean rate is $167.65 compared with Medicare at $0.00 in the provided input, indicating Medicare values are not present in the input.
Rate dispersion (P75 minus P25) varies notably across payers. Cigna exhibits the widest spread (P75 $433.00 minus P25 $89.00 = $344.00), followed by Aetna (P75 $408.00 minus P25 $42.00 = $366.00) and BCBS (P75 $355.00 minus P25 $204.75 = $150.25). UnitedHealth Group shows one of the tightest distributions (P75 $75.00 minus P25 $50.25 = $24.75), and BUCA is relatively tight compared with larger commercial payers (P75 $238.75 minus P25 $47.00 = $191.75). The table and chart below present the full breakdown.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska shows a significant rate spread for CPT code 01930, particularly with Blue Cross Blue Shield, where the difference between the 75th and 25th percentiles is $95.40. BUCA also demonstrates a wide spread of $162.50, indicating substantial variability in reimbursement rates across payers. In contrast, Aetna, Cigna, and UnitedHealth Group have minimal spreads, with all percentiles clustered closely together, suggesting more uniform payment practices.
Compared to national averages, Alaska's mean rates for Aetna and BUCA are notably higher, while Cigna and UnitedHealth Group are lower. The table and chart below present the full breakdown of payer-specific rates and percentiles for Alaska, highlighting the diversity in reimbursement levels across the major commercial payers.
Key Insights for Alaska
- Blue Cross Blue Shield is the highest paying payer in Alaska for CPT 01930, with a mean rate of $327.90.
- UnitedHealth Group offers the lowest mean rate at $74.78.
- Alaska's mean rates for most payers are higher than national averages, especially for Aetna and BUCA, indicating a premium market for this code.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.